Balloon Catheter vs. Basket Catheter in Pancreatic Duct Stone Clearance
- Conditions
- Chronic Pancreatitis
- Registration Number
- NCT05888012
- Lead Sponsor
- Changhai Hospital
- Brief Summary
The aim of the study is to compare the safety and efficacy of the basket catheter with that of the balloon catheter for endoscopic extraction of pancreatic stones.
- Detailed Description
This is a retrospective cohort study. Patients with chronic pancreatitis who underwent ERCP for pancreatic duct stone extraction using either a basket or a balloon catheter were enrolled in this study.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 6493
- CP patients with main pancreatic duct (MPD) stones who underwent ERCP
- Patients had undergone pancreatic surgery or gastrectomy with Billroth II reconstruction prior to the ERCP procedure
- Patients were suspected of having a malignant tumor
- Patients combined with bile duct stones
- Patients had severe pancreatic duct structure
- Patients with insufficient clinical data
- Patients with previous ERCP treatment
- Patients had received both catheters
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the rate of stone clearance in basket and balloon catheter groups 1 year after ERCP complete clearance, defined as fragmentation of the pancreatic stones to \< 3 mm and clearance of more than 90% of the fragments; partial clearance, defined as clearance of 50-90% of the fragments; and unsuccessful clearance, defined as the presence of pancreatic stones ≥ 3 mm or clearance of less than 50% of the fragments.
- Secondary Outcome Measures
Name Time Method the rates of ERCP peri-procedural outcomes and the rates of complications of ERCP in basket and balloon catheter groups 1 year after ERCP ERCP peri-procedural outcomes included difficult cannulation, endoscopic sphincterotomy, dilation of stenosis, and extraction through the minor papilla. Major post-ERCP complications, which were defined according to the Consensus Criteria, included post-ERCP pancreatitis (PEP), bleeding, infection, perforation, and basket impaction
Trial Locations
- Locations (1)
Changhai Hospital
🇨🇳Shanghai, Shanghai, China